Mayflower Financial Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-6,432
Closed -$214K – 355
2022
Q2
$214K Sell
6,432
-575
-8% -$24.4K 0.03% 299
2022
Q1
$505K Sell
7,007
-423
-6% -$30.5K 0.07% 198
2021
Q4
$682K Sell
7,430
-200
-3% -$23.9K 0.09% 157
2021
Q3
$1.07M Sell
7,630
-513
-6% -$74.7K 0.14% 102
2021
Q2
$1.35M Buy
8,143
+681
+9% +$110K 0.19% 83
2021
Q1
$1.36M Buy
7,462
+822
+12% +$191K 0.2% 79
2020
Q4
$1.33M Buy
+6,640
New +$1.35M 0.23% 73

Other funds holding TDOC

Mayflower Financial Advisors's TDOC Position: Q3 2022 in Review

Mayflower Financial Advisors sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 6,432 shares — an estimated $214K sold.

Mayflower Financial Advisors first reported a position in TDOC in Q4 2020 and held it in 7 quarters. The position peaked at $1.36M in Q1 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Mayflower Financial Advisors reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Mayflower Financial Advisors sold 6,432 Teladoc Health shares in Q3 2022, an estimated $214K.
  • Mayflower Financial Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 7 quarters.
  • Mayflower Financial Advisors's Teladoc Health position peaked at $1.36M in Q1 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Mayflower Financial Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.